Selected article for: "antibody cell receptor and cell receptor"

Author: Arnaout, Ramy A.; Prak, Eline T. Luning; Schwab, Nicholas; Rubelt, Florian
Title: The Future of Blood Testing Is the Immunome
  • Cord-id: 1c3nsh2s
  • Document date: 2021_3_15
  • ID: 1c3nsh2s
    Snippet: It is increasingly clear that an extraordinarily diverse range of clinically important conditions—including infections, vaccinations, autoimmune diseases, transplants, transfusion reactions, aging, and cancers—leave telltale signatures in the millions of V(D)J-rearranged antibody and T cell receptor [TR per the Human Genome Organization (HUGO) nomenclature but more commonly known as TCR] genes collectively expressed by a person’s B cells (antibodies) and T cells. We refer to these as the i
    Document: It is increasingly clear that an extraordinarily diverse range of clinically important conditions—including infections, vaccinations, autoimmune diseases, transplants, transfusion reactions, aging, and cancers—leave telltale signatures in the millions of V(D)J-rearranged antibody and T cell receptor [TR per the Human Genome Organization (HUGO) nomenclature but more commonly known as TCR] genes collectively expressed by a person’s B cells (antibodies) and T cells. We refer to these as the immunome. Because of its diversity and complexity, the immunome provides singular opportunities for advancing personalized medicine by serving as the substrate for a highly multiplexed, near-universal blood test. Here we discuss some of these opportunities, the current state of immunome-based diagnostics, and highlight some of the challenges involved. We conclude with a call to clinicians, researchers, and others to join efforts with the Adaptive Immune Receptor Repertoire Community (AIRR-C) to realize the diagnostic potential of the immunome.

    Search related documents:
    Co phrase search for related documents
    • absence presence and adaptive immune: 1, 2, 3, 4, 5
    • absence presence and adaptive immunity: 1, 2, 3, 4
    • absence presence and machine learning: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • activate cell and adaptive immune: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • activate cell and adaptive immunity: 1, 2, 3, 4, 5, 6, 7
    • activation state and adaptive immune: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • activation state and adaptive immunity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • activation state and lymphocytic leukemia: 1
    • adaptive immune and low throughput: 1, 2
    • adaptive immune and lymphocytic leukemia: 1
    • adaptive immune and machine learning: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • adaptive immune receptor and machine learning: 1
    • adaptive immunity and lymphocytic leukemia: 1, 2
    • adaptive immunity and machine learning: 1, 2, 3, 4, 5
    • low throughput and machine learning: 1, 2
    • lymphocytic leukemia and machine learning: 1